These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9917573)

  • 1. Pros and cons of genetic screening for breast cancer.
    Lynch HT; Lynch JF
    Am Fam Physician; 1999 Jan; 59(1):43-4, 46. PubMed ID: 9917573
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
    J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pros and cons of genetic testing for breast and ovarian cancer risk.
    Frank TS; Braverman AM
    Int J Fertil Womens Med; 1999; 44(3):139-45. PubMed ID: 10435912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A literature review of the psychological impact of genetic testing on breast cancer patients.
    Schlich-Bakker KJ; ten Kroode HF; Ausems MG
    Patient Educ Couns; 2006 Jul; 62(1):13-20. PubMed ID: 16242293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological impact of receiving a BRCA1/BRCA2 test result.
    Lodder L; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; van den Ouweland AM; Niermeijer MF
    Am J Med Genet; 2001 Jan; 98(1):15-24. PubMed ID: 11426450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coping with genetic testing for breast cancer susceptibility.
    Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A
    Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
    Hutson SP
    Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
    Michelsen TM; Dørum A; Dahl AA
    Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management of BRCA1 and BRCA2 mutation carriers.
    Domchek SM; Armstrong K; Weber BL
    Nat Clin Pract Oncol; 2006 Jan; 3(1):2-3. PubMed ID: 16407858
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for genetic risk of breast cancer.
    Rosenthal TC; Puck SM
    Am Fam Physician; 1999 Jan; 59(1):99-104, 106. PubMed ID: 9917577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer.
    Meiser B; Collins V; Warren R; Gaff C; St John DJ; Young MA; Harrop K; Brown J; Halliday J
    Clin Genet; 2004 Dec; 66(6):502-11. PubMed ID: 15521977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.
    Pierce L
    Semin Radiat Oncol; 2002 Oct; 12(4):352-61. PubMed ID: 12382193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male to female ratio among offspring of BRCA1 mutation carriers.
    Gronwald J; Byrski T; Huzarski T; Narod SA; Lubinski J
    Breast Cancer Res Treat; 2006 May; 97(1):113-4. PubMed ID: 16319974
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
    Leegte B; van der Hout AH; Deffenbaugh AM; Bakker MK; Mulder IM; ten Berge A; Leenders EP; Wesseling J; de Hullu J; Hoogerbrugge N; Ligtenberg MJ; Ardern-Jones A; Bancroft E; Salmon A; Barwell J; Eeles R; Oosterwijk JC
    J Med Genet; 2005 Mar; 42(3):e20. PubMed ID: 15744030
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of psychological intervention on personality change, coping, and psychological distress of Japanese primary breast cancer patients.
    Maeda T; Kurihara H; Morishima I; Munakata T
    Cancer Nurs; 2008; 31(4):E27-35. PubMed ID: 18600108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological aspects of cancer screening in high-risk populations.
    Kash KM; Dabney MK
    Med Pediatr Oncol; 2001 May; 36(5):519-24. PubMed ID: 11340606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.